U.S. drops contract with Acambis for smallpox vaccine

The U.S. government canceled a contract with the U.K.'s Acambis for providing smallpox vaccine, saying the vaccine maker's new, weakened vaccine was "no longer highly rated" on technical grounds. Acambis CEO Gordon Cameron said he has asked for an urgent meeting with U.S. health authorities to find out why Acambis was dropped. "We believe that our proposal would have met the requirements of the government, especially given our track record in the biodefence field," Cameron said.

View Full Article in:

Independent (London) (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC